Paper7650366
Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes.
D'Andrea A and 5 others. J Immunol, 1995. Cited by 296 papers, by iCite.
Cite this record
ConductScience Library. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. Papers, record 7650366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7650366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cloning, Molecular | Major topic |
| DNA, Complementary | Major topic |
| HLA-B Antigens | Major topic |
| Receptors, Immunologic | Major topic |
| Amino Acid Sequence | |
| Base Sequence | |
| Blotting, Southern | |
| Chromosome Mapping | |
| Clone Cells | |
| Gene Expression | |
| Humans | |
| Killer Cells, Natural | |
| Molecular Sequence Data | |
| RNA, Messenger | |
| Receptors, KIR | |
| Receptors, KIR2DL3 | |
| Receptors, KIR3DL1 | |
| Receptors, KIR3DS1 | |
| T-Lymphocytes |
Source PubMed
Cited by84
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 296 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40660312 | Human iPSC-derived NK cells armed with CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complex enhance anti-solid tumor activity. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/40660312 | PubMed |
| 40246292 | Natural killer cell-based immunotherapy for cancer. | J Immunol | 2025 | https://conductscience.org/library/papers/40246292 | PubMed |
| 39511139 | Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39511139 | PubMed |
| 38842526 | Five decades of natural killer cell discovery. | J Exp Med | 2024 | https://conductscience.org/library/papers/38842526 | PubMed |
| 38202265 | Association of KIR Genes with Middle East Respiratory Syndrome Coronavirus Infection in South Koreans. | J Clin Med | 2024 | https://conductscience.org/library/papers/38202265 | PubMed |
| 37454198 | Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients. | Sci Rep | 2023 | https://conductscience.org/library/papers/37454198 | PubMed |
| 34583856 | Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice. | Hum Immunol | 2022 | https://conductscience.org/library/papers/34583856 | PubMed |
| 33049053 | HLA-A alleles influencing NK cell function impact AML relapse following allogeneic hematopoietic cell transplantation. | Blood Adv | 2020 | https://conductscience.org/library/papers/33049053 | PubMed |
| 32655581 | Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies. | Front Immunol | 2020 | https://conductscience.org/library/papers/32655581 | PubMed |
| 32211339 | N-Glycans Mediate the Ebola Virus-GP1 Shielding of Ligands to Immune Receptors and Immune Evasion. | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/32211339 | PubMed |
| 31231370 | Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation. | Front Immunol | 2019 | https://conductscience.org/library/papers/31231370 | PubMed |
| 26938992 | A vision of KIR variation at super resolution. | Immunology | 2016 | https://conductscience.org/library/papers/26938992 | PubMed |
| 26037048 | The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer. | Curr Top Microbiol Immunol | 2016 | https://conductscience.org/library/papers/26037048 | PubMed |
| 26029215 | Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies. | Front Immunol | 2015 | https://conductscience.org/library/papers/26029215 | PubMed |
| 26013798 | Practical NK cell phenotyping and variability in healthy adults. | Immunol Res | 2015 | https://conductscience.org/library/papers/26013798 | PubMed |
| 25374665 | Natural killer cell regulation - beyond the receptors. | F1000Prime Rep | 2014 | https://conductscience.org/library/papers/25374665 | PubMed |
| 25253288 | Killer immunoglobulin-like receptor gene repertoire influences viral load of primary human cytomegalovirus infection in renal transplant patients. | Genes Immun | 2014 | https://conductscience.org/library/papers/25253288 | PubMed |
| 24856895 | Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease. | Cytotherapy | 2014 | https://conductscience.org/library/papers/24856895 | PubMed |
| 24672522 | Improving the outcome of leukemia by natural killer cell-based immunotherapeutic strategies. | Front Immunol | 2014 | https://conductscience.org/library/papers/24672522 | PubMed |
| 24517425 | The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT). | Immunol Rev | 2014 | https://conductscience.org/library/papers/24517425 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| KIR3DL1 | 3811 | Swiss-Prot's references | https://conductscience.org/library/genes/3811 | NCBI Gene |
| HLA-B | 3106 | PubTator's text mining | https://conductscience.org/library/genes/3106 | NCBI Gene |
| KIR2DL3 | 3804 | PubTator's text mining | https://conductscience.org/library/genes/3804 | NCBI Gene |
Data2
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7650366
GET https://conductscience.org/api/papers/v1/7650366/cited_by?page=2